Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
363.22
+1.24 (0.34%)
Oct 9, 2025, 3:16 PM EDT
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $312.59 billion as of October 9, 2025. Its market cap has increased by 22.93% in one year.
Market Cap
312.59B
Enterprise Value
346.05B
Revenue
79.83B
Ranking
n/a
PE Ratio
26.37
Stock Price
$363.22
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 312.59B, an increase of 3,468.91%. That is a compound annual growth rate of 11.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 311.99B | 37.91% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | 299.05B | 8.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 331.81M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |